1 O O O O
Energy O O O O
and O O O O
Commerce O O O O
Subcommittee O O O O
on O O O O
Oversight O O O O
and O O O O
Investigations O O O O
Hearing O O O O
on O O O O
"Confronting O O O O
a O O O O
Growing O O O O
Public O O O O
Health O O O O
Threat: O O O O
Measles O O O O
Outbreaks O O O O
in O O O O
the O O O O
U.S." O O O O
February O O O O
27, O O O O
2019 O O O O
Questions O O O O
for O O O O
the O O O O
Record O O O O
NIAID O O O O
Director O O O O
Anthony O O O O
Fauci O O O O
The O O O O
Honorable O O O O
Frank O O O O
Pallone O O O O
Jr. O O O O
(D O O O O
-NJ) O O O O
1. O O O O
The Reason 5 O O
Centers Reason 5 ScientificAuthority O
for Reason 5 ScientificAuthority O
Disease Reason 5 ScientificAuthority O
Control Reason 5 ScientificAuthority O
and Reason 5 ScientificAuthority O
Prevention Reason 5 ScientificAuthority O
(CDC) Reason 5 ScientificAuthority O
has Reason 5 O O
determined Reason 5 O O
that Reason 5 O O
recei Reason 5 O O
ving Reason 5 O O
the Reason 5 O O
measles Reason 5 O O
, Reason 5 O O
mumps, Reason 5 O O
and Reason 5 O O
rubella Reason 5 O O
vaccine Reason 5 O O
-known Reason 5 O O
as Reason 5 O O
the Reason 5 O O
MMR Reason 5 O O
vaccine Reason 5 O O
- Reason 5 O O
is Reason 5 O O
safer Reason 5 O O
than Reason 5 O O
getting Reason 5 O O
any Reason 5 O O
of Reason 5 O O
the Reason 5 O O
viruses. Reason 5 O O
CDC Reason 2 O O
notes, Reason 2 O O
however Reason 2 O O
, Reason 2 O O
that Reason 2 O O
as Reason 2 O O
with Reason 2 O O
any Reason 2 O O
medication Reason 2 O O
, Reason 2 O O
there Reason 2 O O
is Reason 2 O O
a Reason 2 O O
chance Reason 2 O O
of Reason 2 O O
adverse Reason 2 O O
reaction. Reason 2 O O
a. O O O O
What O O O O
range O O O O
of O O O O
adverse O O O O
reactions O O O O
are O O O O
associated O O O O
with O O O O
the O O O O
MMR O O O O
vaccine? O O O O
NIAID O O O O
Response O O O O
: O O O O
The O O O O
measles, O O O O
mumps, O O O O
the O O O O
MMRV O O O O
vaccine, O O O O
which O O O O
varicella O O O O
(V O O O O
- O O O O
chickenpox), O O O O
are O O O O
the O O O O
two O O O O
measles O O O O
-containing O O O O
vaccines O O O O
commercially O O O O
available O O O O
in O O O O
the O O O O
United O O O O
States. O O O O
The Reason 5 O O
MMR Reason 5 O O
and Reason 5 O O
MMRV Reason 5 O O
vaccines Reason 5 O O
are Reason 5 O O
97 Reason 5 O O
% Reason 5 O O
effective Reason 5 O O
against Reason 5 O O
measles Reason 5 O O
and Reason 5 O O
both Reason 5 O O
measles Reason 5 O O
-containing Reason 5 O O
vaccines Reason 5 O O
are Reason 5 O O
very Reason 5 O O
safe. Reason 5 O O
The Reason 2 O O
vast Reason 2 O O
majority Reason 2 O O
of Reason 2 O O
individuals Reason 2 O O
who Reason 2 O O
receiv Reason 2 O O
e Reason 2 O O
the Reason 2 O O
vaccines Reason 2 O O
experience Reason 2 O O
no Reason 2 O O
adverse Reason 2 O O
reactions Reason 2 O O
coinciding Reason 2 O O
with Reason 2 O O
vaccination Reason 2 O O
and Reason 2 O O
the Reason 2 O O
most Reason 2 O O
common Reason 2 O O
adverse Reason 2 O O
reactions Reason 2 O O
reported Reason 2 O O
with Reason 2 O O
use Reason 2 O O
of Reason 2 O O
the Reason 2 O O
vaccine Reason 2 O O
s Reason 2 O O
are Reason 2 O O
mild: Reason 2 O O
low Reason 2 O O
-grade Reason 2 O O
fever, Reason 2 O O
injection Reason 2 O O
site Reason 2 O O
redness Reason 2 O O
or Reason 2 O O
rash, Reason 2 O O
temporary Reason 2 O O
stiffness Reason 2 O O
and Reason 2 O O
pain Reason 2 O O
of Reason 2 O O
the Reason 2 O O
joints, Reason 2 O O
and Reason 2 O O
pa Reason 2 O O
in Reason 2 O O
at Reason 2 O O
the Reason 2 O O
injection Reason 2 O O
site. Reason 2 O O
Much Reason 2 O O
less Reason 2 O O
common Reason 2 O O
are Reason 2 O O
temporary Reason 2 O O
adverse Reason 2 O O
reactions Reason 2 O O
reported Reason 2 O O
with Reason 2 O O
use Reason 2 O O
of Reason 2 O O
the Reason 2 O O
vaccines Reason 2 O O
such Reason 2 O O
as: Reason 2 O O
full Reason 2 O O
body Reason 2 O O
rash, Reason 2 O O
low Reason 2 O O
platelet Reason 2 O O
count, Reason 2 O O
and Reason 2 O O
facial Reason 2 O O
swelling. Reason 2 O O
In Reason 2 O O
rare Reason 2 O O
cases, Reason 2 O O
more Reason 2 O O
serious Reason 2 O O
adverse Reason 2 O O
reactions Reason 2 O O
have Reason 2 O O
been Reason 2 O O
reported Reason 2 O O
with Reason 2 O O
use Reason 2 O O
of Reason 2 O O
the Reason 2 O O
vaccines Reason 2 O O
. O O O O
These O O O O
include O O O O
febrile O O O O
seizures, O O O O
which O O O O
can O O O O
be O O O O
caused O O O O
by O O O O
a O O O O
variety O O O O
of O O O O
conditions O O O O
that O O O O
induce O O O O
fever, O O O O
including O O O O
the O O O O
diseases O O O O
that O O O O
the O O O O
vaccines O O O O
are O O O O
designed O O O O
to O O O O
prevent. O O O O
In O O O O
this O O O O
regard, O O O O
up O O O O
to O O O O
five O O O O
percent O O O O
of O O O O
young O O O O
children O O O O
will O O O O
have O O O O
a O O O O
febrile O O O O
seizu O O O O
re O O O O
at O O O O
some O O O O
time O O O O
in O O O O
their O O O O
life, O O O O
usually O O O O
associated O O O O
with O O O O
an O O O O
infection O O O O
that O O O O
they O O O O
have O O O O
contracted. O O O O
Other Reason 2 O O
exceedingly Reason 2 O O
rare Reason 2 O O
adverse Reason 2 O O
reactions Reason 2 O O
reported Reason 2 O O
following Reason 2 O O
use Reason 2 O O
of Reason 2 O O
measles Reason 2 O O
-containing Reason 2 O O
vaccines Reason 2 O O
are Reason 2 O O
anaphylaxis Reason 2 O O
in Reason 2 O O
those Reason 2 O O
with Reason 2 O O
allergies Reason 2 O O
to Reason 2 O O
vaccine Reason 2 O O
components, Reason 2 O O
an Reason 2 O O
d, Reason 2 O O
in Reason 2 O O
extremely Reason 2 O O
rare Reason 2 O O
cases, Reason 2 O O
measles Reason 2 O O
inclusion Reason 2 O O
body Reason 2 O O
encephalitis, Reason 2 O O
almost Reason 2 O O
always Reason 2 O O
in Reason 2 O O
individuals Reason 2 O O
with Reason 2 O O
compromised Reason 2 O O
immune Reason 2 O O
systems. Reason 2 O O
It Reason 2 O O
is Reason 2 O O
important Reason 2 O O
to Reason 2 O O
note Reason 2 O O
that Reason 2 O O
infection Reason 2 O O
with Reason 2 O O
measles Reason 2 O O
virus Reason 2 O O
can Reason 2 O O
result Reason 2 O O
in Reason 2 O O
complications Reason 2 O O
that Reason 2 O O
may Reason 2 O O
include Reason 2 O O
severe, Reason 2 O O
lifelong Reason 2 O O
disabili Reason 2 O O
ty, Reason 2 O O
or Reason 2 O O
even Reason 2 O O
death. Reason 2 O O
About Reason 2 O O
one Reason 2 O O
in Reason 2 O O
ten Reason 2 O O
patients Reason 2 O O
experience Reason 2 O O
ear Reason 2 O O
infections, Reason 2 O O
which Reason 2 O O
can Reason 2 O O
result Reason 2 O O
in Reason 2 O O
deafness, Reason 2 O O
and Reason 2 O O
one Reason 2 O O
in Reason 2 O O
twenty Reason 2 O O
develop Reason 2 O O
pneumonia. Reason 2 O O
One Reason 2 O O
in Reason 2 O O
a Reason 2 O O
thousand Reason 2 O O
are Reason 2 O O
affected Reason 2 O O
by Reason 2 O O
encephalitis, Reason 2 O O
or Reason 2 O O
inflammation Reason 2 O O
of Reason 2 O O
the Reason 2 O O
brain, Reason 2 O O
that Reason 2 O O
can Reason 2 O O
cause Reason 2 O O
seizures Reason 2 O O
and Reason 2 O O
result Reason 2 O O
in Reason 2 O O
deafness Reason 2 O O
or Reason 2 O O
intellectual Reason 2 O O
disability. Reason 2 O O
Two Reason 2 O O
or Reason 2 O O
three Reason 2 O O
infected Reason 2 O O
patients Reason 2 O O
in Reason 2 O O
a Reason 2 O O
thousand Reason 2 O O
will Reason 2 O O
die Reason 2 O O
from Reason 2 O O
measles. Reason 2 O O
In Reason 2 O O
rare Reason 2 O O
cases, Reason 2 O O
a Reason 2 O O
persistent Reason 2 O O
central Reason 2 O O
nervous Reason 2 O O
system Reason 2 O O
infection Reason 2 O O
can Reason 2 O O
also Reason 2 O O
occur, Reason 2 O O
causing Reason 2 O O
a Reason 2 O O
fatal Reason 2 O O
degenerative Reason 2 O O
neurological Reason 2 O O
disease Reason 2 O O
called Reason 2 O O
subacute Reason 2 O O
scler Reason 2 O O
osing Reason 2 O O
panencephalitis Reason 2 O O
(SSPE). Reason 2 O O
SSPE Reason 2 O O
generally Reason 2 O O
develops Reason 2 O O
seven Reason 2 O O
to Reason 2 O O
ten Reason 2 O O
years Reason 2 O O
after Reason 2 O O
measles Reason 2 O O
infection Reason 2 O O
and Reason 2 O O
is Reason 2 O O
characterized Reason 2 O O
by Reason 2 O O
behavioral Reason 2 O O
changes, Reason 2 O O
mental Reason 2 O O
and Reason 2 O O
motor Reason 2 O O
deterioration, Reason 2 O O
seizures, Reason 2 O O
blindness, Reason 2 O O
and Reason 2 O O
ultimately Reason 2 O O
death Reason 2 O O
within Reason 2 O O
one Reason 2 O O
to Reason 2 O O
three Reason 2 O O
years. Reason 2 O O
b. O O O O
Under O O O O
what O O O O
circumstances O O O O
have O O O O
more O O O O
severe O O O O
reactions O O O O
been O O O O
documented? O O O O
2 O O O O
NIAID O O O O
Response O O O O
: O O O O
There O O O O
are O O O O
certain O O O O
individuals O O O O
for O O O O
whom O O O O
measles O O O O
-containing O O O O
vaccines O O O O
are O O O O
medically O O O O
contraindicated O O O O
due O O O O
to O O O O
risk O O O O
of O O O O
severe O O O O
adverse O O O O
reactions. O O O O
It O O O O
is O O O O
important O O O O
that O O O O
parents O O O O
or O O O O
guardians O O O O
have O O O O
a O O O O
conversation O O O O
with O O O O
healthcare O O O O
providers O O O O
to O O O O
ensure O O O O
that O O O O
a O O O O
child O O O O
does O O O O
not O O O O
have O O O O
any O O O O
preexisting O O O O
conditions O O O O
that O O O O
would O O O O
indicate O O O O
they O O O O
should O O O O
not O O O O
receive O O O O
a O O O O
measles O O O O
-containing O O O O
vaccine. O O O O
Package O O O O
inserts1,2 O O O O
for O O O O
measles O O O O
-containing O O O O
vaccines O O O O
contain O O O O
a O O O O
sect O O O O
ion O O O O
pertaining O O O O
to O O O O
warnings O O O O
. O O O O
This O O O O
section O O O O
of O O O O
the O O O O
labeling O O O O
includes O O O O
a O O O O
description O O O O
of O O O O
serious O O O O
adverse O O O O
reactions O O O O
and O O O O
potential O O O O
safety O O O O
risks, O O O O
limitations O O O O
in O O O O
use O O O O
imposed O O O O
by O O O O
them O O O O
and O O O O
steps O O O O
that O O O O
should O O O O
be O O O O
taken O O O O
if O O O O
they O O O O
occur. O O O O
The O O O O
labeling O O O O
also O O O O
includes O O O O
informa O O O O
tion O O O O
pertaining O O O O
to O O O O
contraindications. O O O O
These O O O O
include O O O O
: O O O O
an O O O O
immunodeficiency, O O O O
febrile O O O O
illness O O O O
, O O O O
a O O O O
hypersensitivity O O O O
to O O O O
any O O O O
of O O O O
the O O O O
vaccine O O O O
components, O O O O
or O O O O
an O O O O
anaphylactic O O O O
reaction O O O O
to O O O O
the O O O O
vaccine O O O O
component O O O O
neomycin. O O O O
In Reason 2 O O
addition, Reason 2 O O
measles Reason 2 O O
-containing Reason 2 O O
vaccines Reason 2 O O
are Reason 2 O O
con Reason 2 O O
traindicated Reason 2 O O
in Reason 2 O O
pregnant Reason 2 O O
women. Reason 2 O O
CDC Reason 4 ScientificAuthority O
recommends Reason 4 O O
the Reason 4 O O
first Reason 4 O O
dose Reason 4 O O
of Reason 4 O O
measles Reason 4 O O
-containing Reason 4 O O
vaccine Reason 4 O O
be Reason 4 O O
administered Reason 4 O O
to Reason 4 O O
children Reason 4 O O
between Reason 4 O O
12 Reason 4 O O
to Reason 4 O O
15 Reason 4 O O
months Reason 4 O O
of Reason 4 O O
age Reason 4 O O
in Reason 4 O O
most Reason 4 O O
circumstances. Reason 4 O O
I O O O O
nfants O O O O
6 O O O O
through O O O O
11 O O O O
months O O O O
of O O O O
age O O O O
should O O O O
receive O O O O
one O O O O
dose O O O O
of O O O O
MMR O O O O
vaccine O O O O
if O O O O
the O O O O
y O O O O
will O O O O
be O O O O
traveling O O O O
internationally. O O O O
Recent Reason 2 O O
studies Reason 2 O O
have Reason 2 O O
shown Reason 2 O O
that Reason 2 O O
children Reason 2 O O
who Reason 2 O O
receive Reason 2 O O
a Reason 2 O O
delayed Reason 2 O O
initial Reason 2 O O
MMR Reason 2 O O
vaccine Reason 2 O O
dose Reason 2 O O
after Reason 2 O O
16 Reason 2 O O
months Reason 2 O O
are Reason 2 O O
at Reason 2 O O
an Reason 2 O O
increased Reason 2 O O
risk Reason 2 O O
of Reason 2 O O
febrile Reason 2 O O
seizures. Reason 2 O O
3 O O O O
This O O O O
increased O O O O
risk O O O O
of O O O O
seizure O O O O
lasts O O O O
for O O O O
about O O O O
two O O O O
weeks O O O O
after O O O O
vacc O O O O
ine O O O O
administration O O O O
and O O O O
is O O O O
most O O O O
prevalent O O O O
in O O O O
the O O O O
contraindicated O O O O
group O O O O
of O O O O
children O O O O
with O O O O
a O O O O
history, O O O O
or O O O O
a O O O O
family O O O O
history, O O O O
of O O O O
febrile O O O O
seizures.4 O O O O
The O O O O
MMRV O O O O
vaccine O O O O
also O O O O
has O O O O
been O O O O
shown O O O O
to O O O O
be O O O O
associated O O O O
with O O O O
a O O O O
slightly O O O O
higher, O O O O
but O O O O
still O O O O
very O O O O
low, O O O O
risk O O O O
of O O O O
febrile O O O O
seizures. O O O O
Notably, O O O O
children O O O O
who O O O O
experience O O O O
a O O O O
febrile O O O O
seizure O O O O
after O O O O
vaccination O O O O
are O O O O
at O O O O
no O O O O
greater O O O O
risk O O O O
of O O O O
epilepsy O O O O
long O O O O
-term. O O O O
Exceedingly O O O O
rare O O O O
anaphylactic O O O O
reactions O O O O
to O O O O
the O O O O
MMR O O O O
vaccine O O O O
are O O O O
due O O O O
to O O O O
allergies O O O O
to O O O O
vaccine O O O O
components. O O O O
The Reason 2 O O
MMR Reason 2 O O
vaccine Reason 2 O O
is Reason 2 O O
contra Reason 2 O O
indicated Reason 2 O O
in Reason 2 O O
individuals Reason 2 O O
with Reason 2 O O
a Reason 2 O O
history Reason 2 O O
of Reason 2 O O
an Reason 2 O O
allergic Reason 2 O O
reaction Reason 2 O O
to Reason 2 O O
the Reason 2 O O
vaccine Reason 2 O O
component Reason 2 O O
neomycin Reason 2 O O
due Reason 2 O O
to Reason 2 O O
the Reason 2 O O
presence Reason 2 O O
of Reason 2 O O
trace Reason 2 O O
amounts Reason 2 O O
of Reason 2 O O
this Reason 2 O O
antibiotic Reason 2 O O
in Reason 2 O O
the Reason 2 O O
vaccine. Reason 2 O O
The O O O O
MMR O O O O
vaccine O O O O
also O O O O
uses O O O O
gelatin O O O O
as O O O O
a O O O O
stabilizing O O O O
agent O O O O
to O O O O
maintain O O O O
the O O O O
potency O O O O
of O O O O
t O O O O
he O O O O
vaccine O O O O
when O O O O
exposed O O O O
to O O O O
cold O O O O
or O O O O
hot O O O O
conditions. O O O O
The Reason 2 O O
MMR Reason 2 O O
vaccine Reason 2 O O
is Reason 2 O O
contraindicated Reason 2 O O
in Reason 2 O O
individuals Reason 2 O O
with Reason 2 O O
an Reason 2 O O
allergy Reason 2 O O
to Reason 2 O O
gelatin.5 Reason 2 O O
Individuals Reason 2 O O
with Reason 2 O O
a Reason 2 O O
weakened Reason 2 O O
immune Reason 2 O O
system Reason 2 O O
due Reason 2 O O
to Reason 2 O O
disease Reason 2 O O
(such Reason 2 O O
as Reason 2 O O
primary Reason 2 O O
immunodeficiency, Reason 2 O O
cancer Reason 2 O O
, Reason 2 O O
or Reason 2 O O
HIV/AIDS) Reason 2 O O
or Reason 2 O O
medical Reason 2 O O
treatments Reason 2 O O
(such Reason 2 O O
as Reason 2 O O
chemotherapy, Reason 2 O O
radiation, Reason 2 O O
steroids, Reason 2 O O
or Reason 2 O O
immunotherapy) Reason 2 O O
may Reason 2 O O
be Reason 2 O O
at Reason 2 O O
a Reason 2 O O
greater Reason 2 O O
risk Reason 2 O O
of Reason 2 O O
experiencing Reason 2 O O
rare Reason 2 O O
adverse Reason 2 O O
reactions Reason 2 O O
with Reason 2 O O
use Reason 2 O O
of Reason 2 O O
live Reason 2 O O
attenuated Reason 2 O O
vaccines, Reason 2 O O
including Reason 2 O O
measles Reason 2 O O
-containing Reason 2 O O
vaccines. Reason 2 O O
Apart O O O O
from O O O O
the O O O O
issue O O O O
of O O O O
response O O O O
to O O O O
vaccines, O O O O
individuals O O O O
with O O O O
weakened O O O O
immune O O O O
systems O O O O
are O O O O
unable O O O O
to O O O O
mount O O O O
an O O O O
eff O O O O
ective O O O O
immune O O O O
response O O O O
against O O O O
infectious O O O O
diseases O O O O
such O O O O
as O O O O
measles O O O O
and O O O O
are O O O O
at O O O O
a O O O O
greater O O O O
risk O O O O
of O O O O
viral O O O O
encephalitis O O O O
from O O O O
these O O O O
infections O O O O
